Making gene-edited babies is illegal. This startup says it may be time to reconsider

Origin Genomics is pushing the boundaries of gene-editing technology by attempting to edit disease-causing genes in human embryos, despite the current legal ban on such practices. The company argues that the potential benefits, such as preventing genetic disorders, could be significant enough to warrant reconsidering current laws. This move raises ethical and regulatory questions about the future of genetic modification in humans, sparking debate on the balance between scientific advancement and ethical considerations. The implications could reshape the landscape of biotechnology and our understanding of genetic intervention.